StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Aspira Women's Health's operating income for the twelve months ending Jun 30, 2026 was -$6.90M. For fiscal 2025 it was -$7.91M. The highest annual figure on record is -$7.91M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.91M–
FY2024Dec 31, 2024-$16.28M–
FY2023Dec 31, 2023-$18.85M–
FY2022Dec 31, 2022-$31.14M–
FY2021Dec 31, 2021-$32.60M–
FY2020Dec 31, 2020-$17.98M–
FY2019Dec 31, 2019-$15.28M–
FY2018Dec 31, 2018-$11.33M–
FY2017Dec 31, 2017-$10.44M–
FY2016Dec 31, 2016-$14.95M–
FY2015Dec 31, 2015-$19.25M–
FY2014Dec 31, 2014-$19.21M–
FY2013Dec 31, 2013-$8.86M–
FY2012Dec 31, 2012-$9.41M–
FY2011Dec 31, 2011-$17.64M–
FY2010Dec 31, 2010-$14.60M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.84M–
Q1 FY2026Mar 31, 2026-$2.20M–
Q4 FY2025Dec 31, 2025-$1.28M–
Q3 FY2025Sep 30, 2025-$1.58M–
Q2 FY2025Jun 30, 2025-$1.81M–
Q1 FY2025Mar 31, 2025-$3.24M–
Q4 FY2024Dec 31, 2024-$3.43M–
Q3 FY2024Sep 30, 2024-$3.74M–
Q2 FY2024Jun 30, 2024-$4.39M–
Q1 FY2024Mar 31, 2024-$4.71M–
Q4 FY2023Dec 31, 2023-$4.14M–
Q3 FY2023Sep 30, 2023-$4.12M–
Q2 FY2023Jun 30, 2023-$4.32M–
Q1 FY2023Mar 31, 2023-$6.28M–
Q4 FY2022Dec 31, 2022-$5.09M–
Q3 FY2022Sep 30, 2022-$8.58M–
Q2 FY2022Jun 30, 2022-$8.22M–
Q1 FY2022Mar 31, 2022-$9.25M–
Q4 FY2021Dec 31, 2021-$8.95M–
Q3 FY2021Sep 30, 2021-$9.69M–
Q2 FY2021Jun 30, 2021-$8.07M–
Q1 FY2021Mar 31, 2021-$5.89M–
Q4 FY2020Dec 31, 2020-$6.07M–
Q3 FY2020Sep 30, 2020-$4.28M–
Q2 FY2020Jun 30, 2020-$3.83M–
Q1 FY2020Mar 31, 2020-$3.80M–
Q4 FY2019Dec 31, 2019-$3.40M–
Q3 FY2019Sep 30, 2019-$3.85M–
Q2 FY2019Jun 30, 2019-$4.31M–
Q1 FY2019Mar 31, 2019-$3.72M–
Q4 FY2018Dec 31, 2018-$2.82M–
Q3 FY2018Sep 30, 2018-$2.64M–
Q2 FY2018Jun 30, 2018-$3.03M–
Q1 FY2018Mar 31, 2018-$2.84M–
Q4 FY2017Dec 31, 2017-$2.94M–
Q3 FY2017Sep 30, 2017-$2.50M–
Q2 FY2017Jun 30, 2017-$2.35M–
Q1 FY2017Mar 31, 2017-$2.66M–
Q4 FY2016Dec 31, 2016-$2.83M–
Q3 FY2016Sep 30, 2016-$3.47M–

More Aspira Women's Health figures

See a number that looks wrong?